Avanos Recalls Ballard Closed Suction Systems
Due to sterilization failureMay result in non-sterile devices
Avanos Medical, Inc. is recalling its Ballard Closed Suction Systems after identifying a failure in the sterilization process, which may result in non-sterile devices. Use of these products could lead to serious health risks, including infection, airway injury, inflammation, sepsis, or death.
No injuries or deaths have been reported to date.
About the Device
The Ballard Closed Suction System is used for removing airway secretions in ventilated patients, helping to maintain ventilation without disconnecting the circuit — a critical function in respiratory care.
Recommended Actions (as of March 19, 2025)
- Immediately stop using any affected products and quarantine them.
- Check your inventory for affected items listed in the recall notice.
- Notify any customers or departments you may have shared the product with.
- Complete and return the Response Form to: productquality@myairlife.com.
- Arrange for return or confirm destruction of affected units to receive replacements.
- Communicate the recall to all relevant staff within your organization.
- For urgent replacement needs, contact AirLife at 1-800-433-2797.
Need Help?
For questions or support related to the recall, contact Avanos Medical, Inc. at 1-800-433-2797.
Healthcare providers are urged to act promptly to prevent potential harm to patients relying on these critical airway management systems.
Affected Products
Affected Product
Product Names:
- Ballard Closed Suction System for Neonates/Pediatrics, 8 F, Y-Adapter
- Ballard Closed Suction System for Neonates/Pediatrics, 10 F, Elbow
- Ballard Closed Suction System for Neonates/Pediatrics, 8 F, Elbow
- Ballard Closed Suction System for Adults, 14 F, T-Piece
- Ballard Closed Suction System for Adults, 14 F, DSE
- Ballard Turbo-Cleaning Closed Suction System for Adults, 14 F, DSE, MDI
- Ballard Turbo-Cleaning Closed Suction System for Adults, 14 F, DSE
Click here to see a full list of affected devices.
FDA’s Orphan Drug Program
Expedite Development of New Orphan Drugs The FDA's Orphan Drug Program is designed to encourage the development of drugs and biologics for the treatment, diagnosis, or prevention of rare diseases or conditions, often referred to as orphan diseases. Here are the key...
Medical Devices and Pharmaceuticals
At Medical Devices and Pharma, we specialize in providing top-tier regulatory consulting services tailored to the medical device and pharmaceutical industries. Our deep understanding of policy, laws, regulations, and industry standardsand requirements will ensure your...
Risks with Exactech Equinoxe Shoulder System
FDA Safety Communication April 19 Update: Exactech has initiated a recall to remove Equinoxe Shoulder System devices packaged in the defective bags from facilities’ unused inventory. To see if your device is affected by the recall, visit Exactech’s Recall...